148 related articles for article (PubMed ID: 2773772)
1. Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
Hasenfuss G; Holubarsch C; Heiss HW; Just H
Am Heart J; 1989 Sep; 118(3):512-9. PubMed ID: 2773772
[TBL] [Abstract][Full Text] [Related]
2. Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside.
Hasenfuss G; Holubarsch C; Heiss HW; Rattert B; Just H
Basic Res Cardiol; 1989; 84 Suppl 1():225-33. PubMed ID: 2818456
[TBL] [Abstract][Full Text] [Related]
3. Effects of pimobendan on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
Hasenfuss G; Holubarsch C; Heiss HW; Allgeier M; Just H
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S31-5. PubMed ID: 2478789
[TBL] [Abstract][Full Text] [Related]
4. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
Permanetter B; Sebening H; Busch U; Lutilsky L
Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy.
Permanetter B; Sebening H; Hartmann F; Baumann G; Lutilsky L
J Cardiovasc Pharmacol; 1989 Dec; 14(6):803-9. PubMed ID: 2481765
[TBL] [Abstract][Full Text] [Related]
6. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone.
Hasenfuss G; Holubarsch C; Heiss HW; Meinertz T; Bonzel T; Wais U; Lehmann M; Just H
Circulation; 1989 Jul; 80(1):51-64. PubMed ID: 2525432
[TBL] [Abstract][Full Text] [Related]
7. Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy.
Holubarsch C; Hasenfuss G; Heiss WH; Just H
Am J Cardiol; 1988 Sep; 62(8):104E-107E. PubMed ID: 2970783
[TBL] [Abstract][Full Text] [Related]
8. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
Holubarsch C; Hasenfuss G; Thierfelder L; Just H
Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
[TBL] [Abstract][Full Text] [Related]
10. The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
Thierfelder L; Holubarsch C; Hasenfuss G; Heiss HW; Just H
J Cardiovasc Pharmacol; 1991 Apr; 17(4):593-9. PubMed ID: 1711626
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Baumann G; Ningel K; Permanetter B
J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
[TBL] [Abstract][Full Text] [Related]
12. Influence of enoximone on myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
Hasenfuss G; Holubarsch C; Heiss HW; Meinertz T; Hofmann T; Just H
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S69-74. PubMed ID: 2480489
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW
J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
[TBL] [Abstract][Full Text] [Related]
14. [Acute effect of the cardioselective beta-1-partial agonist, Corwin, on ventricular function and myocardial oxygen consumption in patients with dilated cardiomyopathy].
Amende I; Simon R; Hood WP; Lichtlen PR
Z Kardiol; 1986 May; 75(5):291-5. PubMed ID: 2874668
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of intravenous UD-CG 115 BS (pimobendan) on the cardiovascular system and left ventricular pump function.
Permanetter B; Sebening H; Hartmann F; Klein G
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S36-40. PubMed ID: 2478790
[TBL] [Abstract][Full Text] [Related]
16. Myocardial energetics in dilated cardiomyopathy.
Thierfelder L; Holubarsch CH; Hasenfuss G; Just HJ
Clin Cardiol; 1990 Sep; 13(9):649-54. PubMed ID: 1976466
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.
Eichhorn EJ; Bedotto JB; Malloy CR; Hatfield BA; Deitchman D; Brown M; Willard JE; Grayburn PA
Circulation; 1990 Aug; 82(2):473-83. PubMed ID: 1973638
[TBL] [Abstract][Full Text] [Related]
18. [Acute and chronic effects of UDCG 115 BS (pimobendan) in patients with advanced myocardial failure].
Permanetter B; Baumann G; Wirtzfeld A; Günes S; Stinshoff M; Klein G
Z Kardiol; 1989 May; 78(5):335-42. PubMed ID: 2660451
[TBL] [Abstract][Full Text] [Related]
19. Separation of afterload reduction and a direct beneficial cardiac effect of nifedipine in congestive cardiomyopathy.
Percy RF; Bass TA; Conetta DA; Miller AB
Clin Cardiol; 1989 Aug; 12(8):435-40. PubMed ID: 2766589
[TBL] [Abstract][Full Text] [Related]
20. Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Smucker ML; Sanford CF; Lipscomb KM
Am J Cardiol; 1985 Oct; 56(10):690-5. PubMed ID: 4050708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
